NASDAQ | ETF
The index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of telemedicine and digital health, as well as applications thereof (collectively, Telemedicine & Digital Health Companies), as defined by Solactive AG, the provider of the index.
The Adviser uses a passive or indexing approach to try to achieve the fund's investment objective.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| RMD | Resmed Inc DRC | Healthcare | Medical Instruments & Supplies | 5.78% |
| DOCS | Doximity Inc | Healthcare | Health Information Services | 5.01% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 4.50% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 4.41% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 4.32% |
| PME | Pro Medicus Ltd | Healthcare | Health Information Services | 4.31% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 4.18% |
| DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 4.10% |
| RMD | ResMed Inc | Healthcare | Medical Instruments & Supplies | 4.01% |
| HIMS | Hims Hers Health Inc | Consumer Defensive | Household & Personal Products | 3.90% |
| 6618 | Jd Health International Inc | Healthcare | Pharmaceutical Retailers | 3.87% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.87% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 3.79% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.71% |
| OSCR | Oscar Health Inc | Healthcare | Healthcare Plans | 3.70% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.64% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.33% |
| 0241 | Alibaba Health Information Technology Ltd | Healthcare | Pharmaceutical Retailers | 3.28% |
| IRTC | iRhythm Technologies Inc | Healthcare | Medical Devices | 3.16% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 3.11% |